Latest Portfolio Expansion News

Eclipse Metals Ltd reports a transformative quarter with a massive upgrade to its Greenland rare earth resource and strategic advances in its uranium portfolio, backed by a $2 million capital raise.

Hastings Technology Metals has formalized a 60 – 40 unincorporated joint venture with Wyloo for the Yangibana Rare Earths and Niobium Project, significantly reducing capital costs and advancing development. The company also moves to diversify with a conditional acquisition of the Whiteheads Gold Project and appoints Vince Catania as CEO.

Advance Metals reports robust exploration results with standout gold grades at Myrtleford and significant silver-gold intersections at Yoquivo, while advancing acquisitions that broaden its Mexican portfolio.

Buxton Resources reports significant progress across its exploration portfolio, including earthworks at Centurion, heritage survey completion at Madman, and a major graphite testwork success, while regaining full control of Fraser Range after IGO's exit.

Delta Lithium has completed the demerger and IPO of its Mt Ida Gold asset into Ballard Mining, raising $30 million and retaining a 46% stake, while significantly expanding its lithium project tenure in Western Australia.

Scalare Partners has raised $3 million through a share placement to fund its acquisition of Tank Stream Labs, alongside a $1.08 million Share Purchase Plan for existing shareholders. This capital raise aims to bolster Scalare’s position in the flexible workspace and tech investment sectors.

TALi Digital has completed a modest capital raise through a 1-for-6 entitlement offer, coinciding with its strategic acquisition of You Can Do It! Education, signaling a push into social-emotional learning.

Island Pharmaceuticals has accelerated its acquisition of the Galidesivir antiviral program from BioCryst Pharmaceuticals, adding a clinically advanced asset with significant US government backing and a promising regulatory pathway.

360 Capital Mortgage REIT has successfully raised A$1.71 million by issuing 288,540 new units under a non-underwritten Unit Purchase Plan, strengthening its capital base without incurring brokerage costs.

SunRice reported a slight decline in FY25 revenue to $1.85 billion but achieved improved profitability, driven by strategic acquisitions and operational efficiencies. The company is investing in sustainability and capacity upgrades as it pursues its 2030 Growth Strategy.

Paradigm Biopharmaceuticals has acquired Proteobioactives, securing global rights to an oral combination therapy targeting early-stage osteoarthritis in humans and animals, complementing its injectable PPS phase 3 program.

Unico Silver Limited has reported its highest silver intercept to date at the Cerro Leon project, delivering significant near-surface and deeper mineralisation that underpins its dual-track growth strategy.